Lindbrook Capital, LLC Becton Dickinson & CO Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,068 shares of BDX stock, worth $240,983. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,068

Previous 1,105 3.35%

Holding current value

$240,983

Previous $258,000 0.39%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$221.47 - $242.41 $8,194 - $8,969	-37 Reduced 3.35%	1,068 $257,000
Q2 2024 Jul 31, 2024	BUY	$225.07 - $246.17 $33,985 - $37,171	151 Added 15.83%	1,105 $258,000
Q1 2024 Apr 25, 2024	BUY	$233.45 - $247.73 $8,404 - $8,918	36 Added 3.92%	954 $236,000
Q4 2023 Jan 31, 2024	SELL	$232.24 - $267.23 $27,172 - $31,265	-117 Reduced 11.3%	918 $223,000
Q3 2023 Oct 25, 2023	BUY	$254.9 - $283.59 $3,823 - $4,253	15 Added 1.47%	1,035 $267,000
Q2 2023 Jul 28, 2023	BUY	$238.39 - $265.32 $7,390 - $8,224	31 Added 3.13%	1,020 $269,000
Q1 2023 Apr 26, 2023	BUY	$229.71 - $259.35 $10,566 - $11,930	46 Added 4.88%	989 $244,000
Q4 2022 Jan 24, 2023	SELL	$218.29 - $256.91 $291,853 - $343,488	-1,337 Reduced 58.64%	943 $0
Q3 2022 Nov 10, 2022	BUY	$51.03 - $264.23 $5,256 - $27,215	103 Added 4.73%	2,280 $508,000
Q2 2022 Aug 01, 2022	SELL	$234.74 - $275.42 $39,201 - $45,995	-167 Reduced 7.12%	2,177 $537,000
Q1 2022 Apr 21, 2022	SELL	$243.64 - $270.48 $243 - $270	-1 Reduced 0.04%	2,344 $624,000
Q4 2021 Jan 18, 2022	BUY	$230.08 - $250.94 $54,068 - $58,970	235 Added 11.14%	2,345 $590,000
Q3 2021 Nov 05, 2021	BUY	$232.72 - $256.47 $3,025 - $3,334	13 Added 0.62%	2,110 $519,000
Q2 2021 Jul 27, 2021	SELL	$232.65 - $254.58 $3,489 - $3,818	-15 Reduced 0.71%	2,097 $510,000
Q1 2021 Apr 28, 2021	BUY	$232.09 - $256.88 $5,802 - $6,422	25 Added 1.2%	2,112 $514,000
Q4 2020 Jan 27, 2021	BUY	$221.92 - $245.94 $2,219 - $2,459	10 Added 0.48%	2,087 $522,000
Q3 2020 Nov 03, 2020	SELL	$215.77 - $276.76 $5,394 - $6,919	-25 Reduced 1.19%	2,077 $483,000
Q2 2020 Jul 27, 2020	BUY	$219.9 - $263.41 $55,194 - $66,115	251 Added 13.56%	2,102 $503,000
Q1 2020 Apr 22, 2020	SELL	$195.69 - $279.01 $24,852 - $35,434	-127 Reduced 6.42%	1,851 $425,000
Q4 2019 Jan 27, 2020	SELL	$236.45 - $266.82 $19,152 - $21,612	-81 Reduced 3.93%	1,978 $538,000
Q3 2019 Oct 31, 2019	BUY	$230.58 - $256.08 $5,303 - $5,889	23 Added 1.13%	2,059 $521,000
Q2 2019 Jul 24, 2019	BUY	$217.4 - $246.08 $2,391 - $2,706	11 Added 0.54%	2,036 $513,000
Q4 2018 Feb 07, 2019	BUY	$204.73 - $257.93 $414,578 - $522,308	2,025 New	2,025 $456,000

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

251M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Becton Dickinson & CO Transaction History